Back to All Events

Best of ASCO GI Cancer

  • The Darcy 1515 Rhode Island Avenue Northwest Washington, DC, 20005 United States (map)

Hybrid Event | 5.50 CE/CME Credits & MOC Points

Total Health's 2025 Best of ASCO GI Conference is an officially licensed Best of ASCO meeting. This Post ASCO Review showcases abstracts from highly rated presentations, allowing attendees to engage with the latest research and strategies in oncology education. This accredited meeting will be hosted as a hybrid conference only with on-demand access for registered attendees.

 

Conference Agenda
Saturday, April 5, 2025

7:30 AM
Coffee and Exhibits

8:00 AM
Program Chair Welcome

8:10 AM
Emerging Therapies: Bispecifics and ADCs

8:30 AM
Theranostics in GI Cancers

8:50 AM
Breakfast and Exhibits

9:05 AM
Non-CME Breakfast

9:50 AM
Advancements in Systemic Therapy in Gastroesophageal Cancers

10:10 AM
Radioligand Therapy and Targeted Therapies for Esophageal and GE Junction Cancers

10:30 AM
Risk Assessment Biomarkers for Pancreaticobiliary Cancers

10:50 AM
Panel Discussion: Multidisciplinary Care in Upper GI Cancers

11:10 AM
Lunch and Exhibits

11:25 AM
Non-CME Lunch

12:10 PM
Housekeeping and Survey

12:20 PM
Blood-Based Testing for Colorectal Cancer: Pipeline and Practice

12:40 PM
Integrative Oncology: Mindfulness, Nutrition, and Physical Activity in GI Cancers

1:00 PM
The Role of the Microbiome in GI Cancer Care

1:20 PM
Break and Exhibits

1:35 PM
Adjuvant Therapy for Resectable HCC: Pro and Con Debate

1:55 PM
Updates in Immunotherapy for MSS Colon Cancer

2:15 PM
Cancer Vaccines: Progress on the Promise?

2:35 PM
Panel Discussion: Controversies in GI Oncology

2:55 PM
Break and Exhibits

3:10 PM
Advances in Systemic Therapies for Pancreaticobiliary Cancers

3:30 PM
Expanding the Limits of Endoscopic Therapy for Early GI Cancers

3:50 PM
Patient Empowerment: Survivorship and Supportive Care

4:10 PM
Closing Panel: Key Takeaways and Audience Q&A

4:40 PM
Adjourn

Agenda Subject To Change. All times are EST.

 
    • Review and analyze the latest therapeutic advances for the treatment and management of GI cancer.

    • Apply new data and therapeutic advances into guideline-driven treatment strategies to improve the care of patients with GI cancers, neuroendocrine tumors, and hepatocellular cancers

    • Identify subpopulations of patients with gastrointestinal cancers most likely to benefit from a specific treatment plan based on prognostic or predictive markers

    • Evaluate the role of ctDNA and MRD in GI cancers

  • In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Total Health. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    Nurses (ANCC) Credit Designation

    Amedco LLC designates this activity for a maximum of 5.50 ANCC contact hours.

    Physicians (ACCME) Credit Designation

    Amedco LLC designates this live activity for a maximum of 5.50 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Pharmacists and Pharmacy Technicians (ACPE) Credit Designation

    Amedco LLC designates this activity for a maximum of 5.50 knowledge-based CPE contact hours.

    NOTE to Pharmacists: The only official Statement of Credit is the one you pull from CPE Monitor. You must request your certificate within 30 days of your participation in the activity to meet the deadline for submission to CPE Monitor.

    American Board of Internal Medicine (ABIM) MOC Credit

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 5.50 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. You must request your certificate within 30 days of the activity to meet the deadline for submission to PARS.

    • Free registration for all healthcare providers

    • Expert sessions that present the most clinically relevant data, research, and clinical strategies

    • Real-time discussion and debate

    • Networking with peers, colleagues, and medical professionals

    • Access to the latest industry information and resources

 
Previous
Previous
April 5

Oncology Clinical Updates - Review and Renew

Next
Next
April 10

Cancer Updates GI and Breast